Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ: NARI )

79.93 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
From Inari Medical, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Looking Into Inari Medical's Return On Invested Capital
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
Inari Medical: Q1 Earnings Insights
Via Benzinga
Why Shares of Inari Medical Rose This Week
The medical equipment maker's stock has climbed by $10 a share since the start of the month. 
Via The Motley Fool
Inari Medical to Announce Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces the Release of 2022 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Earnings Preview
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
What 6 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Find out why the investment bankers who follow these stocks think they can soar in the near term. 
Via The Motley Fool
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Inari Medical, Inc.
Via GlobeNewswire
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
From Inari Medical, Inc.
Via GlobeNewswire
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
These companies are reporting financial results that aren't being reflected in their stock market performances. 
Via The Motley Fool
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would suggest. 
Via The Motley Fool
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Inari Medical, Inc.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.